Drugmaker Eli Lilly announced Wednesday it will reduce prices for some of its most commonly prescribed insulin products by up by to 70%, and expand a monthly $35 cap on prescription costs for insured patients. CBS News correspondent Lilia Luciano reported on the government's role in the process.
